Ascendiant Capital Markets Issues Positive Forecast for Aemetis (NASDAQ:AMTX) Stock Price

Aemetis (NASDAQ:AMTX) had its price target boosted by Ascendiant Capital Markets from $20.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the specialty chemicals company’s stock.

Several other equities research analysts also recently issued reports on AMTX. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Saturday, September 27th. UBS Group upped their price objective on Aemetis from $2.20 to $3.00 and gave the stock a “buy” rating in a research report on Monday, June 30th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $17.33.

Aemetis Stock Performance

AMTX opened at $2.65 on Monday. The company has a fifty day moving average price of $2.50 and a two-hundred day moving average price of $2.17. The firm has a market capitalization of $167.59 million, a PE ratio of -1.64 and a beta of 1.68. Aemetis has a 52 week low of $1.22 and a 52 week high of $4.73.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Thursday, August 7th. The specialty chemicals company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.06). The company had revenue of $52.24 million during the quarter, compared to analyst estimates of $78.68 million. Equities analysts forecast that Aemetis will post -2.07 EPS for the current year.

Insiders Place Their Bets

In related news, Director Francis P. Barton sold 26,452 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $2.53, for a total value of $66,923.56. Following the completion of the sale, the director directly owned 208,518 shares in the company, valued at approximately $527,550.54. The trade was a 11.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 15.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Aemetis

Several hedge funds have recently bought and sold shares of the company. Catalyst Funds Management Pty Ltd bought a new position in Aemetis in the second quarter valued at approximately $25,000. R Squared Ltd acquired a new position in shares of Aemetis during the 2nd quarter worth $30,000. Creative Planning bought a new stake in shares of Aemetis during the 2nd quarter worth $30,000. Engineers Gate Manager LP acquired a new stake in Aemetis in the second quarter valued at about $42,000. Finally, Ethic Inc. bought a new position in Aemetis in the second quarter valued at about $42,000. 27.02% of the stock is owned by institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.